Who owns AVALO THERAPEUTICS ORD?
- Ticker: AVTX
- CUSIP Number: 05338f306
Tip: Access positions for across all investors
Analyze quarterly positions in Avalo Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avalo Therapeutics Ord stock
Who bought or sold AVALO THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 970k | $9.2M | 1673% | Sep 2024 |
|
| OrbiMed Advisors | 967k | $9.2M | 100% | Sep 2024 |
|
| RA Capital Management | 967k | $9.2M | 100% | Sep 2024 |
|
| BVF | 967k | $9.1M | 100% | Sep 2024 |
|
| Logos Global Management | 539k | $6.7M | 100% | Jun 2024 |
|
| Commodore Capital | 483k | $4.6M | 1108% | Sep 2024 |
|
| Sio Capital Management | 72k | $891k | 604% | Jun 2024 |
|
| Affinity Asset Advisors | 45k | $426k | 0% | Sep 2024 |
|
| Vanguard Group | 10k | $129k | 100% | Jun 2024 |
|
| Geode Capital Management | 10k | $96k | 100% | Sep 2024 |
|
| Bank of America Corporation | 5.6k | $53k | 0% | Sep 2024 |
|
| BlackRock | 329.00 | $3.1k | 100% | Sep 2024 |
|
| BlackRock | 329.00 | $4.1k | -85% | Jun 2024 |
|
| Morgan Stanley | 10.00 | $124.286000 | -74% | Jun 2024 |
|
| Efficient Wealth Management | 5.00 | $0 | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.00 | $38.000000 | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 2.00 | $19.000000 | 0% | Sep 2024 |
|
| Advisor Group Holdings | 2.00 | $18.000000 | 0% | Sep 2024 |
|
| Group One Trading | 2.00 | $19.000000 | 0% | Sep 2024 |
|
| Key FInancial | 1.00 | $10.000000 | 0% | Sep 2024 |
|
| Jaffetilchin Investment Partners | 1.00 | $10.000000 | 100% | Sep 2024 |
|
| Activest Wealth Management | 1.00 | $10.000000 | 0% | Sep 2024 |
|
| Wells Fargo & Company | 1.00 | $10.000000 | 0% | Sep 2024 |
|
| Parallel Advisors | 1.00 | $10.000000 | 0% | Sep 2024 |
|
Who sold out of Avalo Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tower Research Capital | Mar 2024 | 1.6k | $36k |
| Royal Bank of Canada | Jun 2024 | 590.00 | $7.0k |
| Banque Cantonale Vaudoise | Jun 2024 | 338.00 | $4.0k |